Quotes 5-day view Delayed Nyse
06/23/2022
06/24/2022
06/27/2022
06/28/2022
06/29/2022
Date
49.94(c)
51.23(c)
51.57(c)
51.11(c)
51.56
Last
1 226 956
2 377 114
1 291 221
1 430 957
1 608 159
Volume
+0.38%
+2.58%
+0.66%
-0.89%
+0.88%
Change
Estimated financial data (e) (USD)
Sales 2022
4 175 M
-
-
Net income 2022
66,9 M
-
-
Net Debt 2022
12 803 M
-
-
P/E ratio 2022
299x
Yield 2022
3,50%
Sales 2023
4 503 M
-
-
Net income 2023
183 M
-
-
Net Debt 2023
12 025 M
-
-
P/E ratio 2023
122x
Yield 2023
3,78%
Capitalization
20 608 M
20 608 M
-
EV / Sales 2022
8,00x
EV / Sales 2023
7,25x
Nbr of Employees
434
Free-Float
99,5%
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2021, the group's portfolio included 1,242 assets consisting of rest homes (821), medical office facilities (313), laboratories and research facilities (43), rehabilitation and long-term acute care facilities (36), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are...
06/23 Credit Suisse Initiates 24 REIT Stocks, Names 5 Top Picks, Says Inflation Protection to.. MT
06/22 BMO Capital Lowers Ventas' Price Target to $57 From $64, Maintains Outperform Rating MT
06/22 Pamela Boneham Joins Ventas Investment Management Platform as Senior Strategic Advisor BU
06/22 Ventas, Inc. Appoints Pamela Boneham as Senior Strategic Advisor to Its Ventas Investme.. CI
06/08 TRANSCRIPT : Ventas, Inc. Presents at Nareits REITweek: 2022 Investor Conference, Ju..CI
06/06 Ventas to Present at Nareit's REITweek 2022 Investor Conference BU
06/01 VENTAS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Even..AQ
06/01 Morgan Stanley Adjusts Ventas' Price Target to $59 from $61.50, Keeps Equalweight Ratin.. MT
05/31 Berenberg Bank Adjusts Ventas' Price Target to $60 From $57, Maintains Hold Rating MT
05/25 Ventas Maintains Quarterly Dividend at $0.45 a Share, Payable July 14 to Shareholders a.. MT
05/25 Ventas Declares Second Quarter 2022 Dividend of $0.45 per Common Share BU
05/25 Ventas, Inc. Declares Second Quarter 2022 Dividend, Payable on July 14, 2022 CI
05/20 RBC Lifts Price Target on Ventas to $63 From $62, Maintains Outperform Rating MT
05/19 Ventas Named a Top Corporate Citizen of 2022 by 3BL Media BU
05/18 Ventas's Outlook Revised by S&P Global Ratings to Stable BU
News in other languages on VENTAS
Analyst Recommendations on VENTAS
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends VENTAS
Short Term Mid-Term Long Term Trends Bearish Bearish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
51,56 $
Average target price
63,18 $
Spread / Average Target
22,5%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capi. (M$)
VENTAS -0.02% 20 428